Flunil 20 MG Capsule

This medicine is primarily used for the treatment of major depression; treatment of binge-eating and vomiting in patients with moderate-to-severe bulimia nervosa;. It is also used for treating obsessive-compulsive disorder.

Flunil 20 MG Capsule is used for the treatment of obsessive-compulsive disorder (OCD), depression, sudden panic attacks, bulimia (eating disorder) and premenstrual dysphoric disorder (symptoms of tension, irritability and depression before menstruation). The medication can improve your sleep, mood, appetite as well as the energy level.

It belongs to the drug group known as selective serotonin reuptake inhibitors (SSRIs). It works by increasing the serotonin amount in your body, which is a natural substance present in your brain that helps in maintaining mental balance.

Flunil 20 MG Capsule dosage will depend on your present health condition and how your body reacts to the first dose. Your doctor may prescribe a low dose initially and then increase it gradually.

It is advised not to stop the medication abruptly without consulting your doctor, as there is a possibility of experiencing withdrawal symptoms such as mood changes, dizziness, anxiety, confusion, agitation or irritability. It may take 4-5 weeks and sometimes even longer for Flunil 20 MG Capsule to show its full effectiveness.

You can suffer from mild side effects like nervousness, nausea, dry mouth, weakness, drowsiness and decreased sexual performance while taking Flunil 20 MG Capsule. You can consult your doctor if they refuse to go away after some time. However, there can be some serious side effects too in some cases that require immediate medical attention:

• Allergic reaction to the medicine, causing difficulty in breathing, rashes, hives, swelling of the face and lips
• Pain in the eyes or blurry vision
• Palpitations or faster heart rate
• Seizures, tremors, hallucinations or suicidal tendencies
• Unusual bruising or bleeding

Flunil 20 MG Capsule can make you feel drowsy or dizzy. It is advised not to drive or do any other activity that requires your complete concentration. In case you are an elderly patient, be careful when you are getting up from a sitting or sleeping position to avoid a sudden fall. Also, you must avoid alcohol while you are under this medication.

Following conditions can be restored by utilising this prescription:

• Bulimia

• Depression

• Obsessive Compulsive Disorder (Ocd)

• Panic Disorder

• Premenstrual Dysphoric Disorder

• Allergy

• Monoamine oxidase inhibitors

Here are some possible side effects of this medication

• Headache

• Nervousness

• Insomnia

• Anxiety

• Nausea

• Diarrhoea

• Anorexia

• Weakness

• Vasodilation

• Hypertension

• Confusion

• Sleep Disorders

• Dizziness

• Agitation

• Rash

• Pruritus

• Tremor

• Increased Appetite

• Dyspepsia

• Vomiting

• Flatulence

• How long is the duration of effect?

  The effect of this medication lasts for an average duration of 12 to 14 days.

• What is the onset of action?

  The peak effect of this medication can be observed in 6 to 8 hours.

• Are there any pregnancy warnings?

  This medication is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine.

• Is it habit forming?

  No habit forming tendency has been reported

• Are there any breast-feeding warnings?

  This medication is not recommended for use in breastfeeding women unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine. Monitoring of undesired effects like colic, fussiness, and drowsiness is necessary.

• Does this affect kidney function?

  Dosing adjustment in renal impairment:
  • Single dose studies: Pharmacokinetics of fluoxetine and norfluoxetine were similar among subjects with all levels of impaired renal function, including anephric patients on chronic hemodialysis.
  • Chronic administration: Additional accumulation of fluoxetine or norfluoxetine may occur in patients with severely impaired renal function.
  • Hemodialysis: Not removed by hemodialysis.

• Does this affect liver function?

  Dosing adjustment in renal impairment:Elimination half-life of fluoxetine is prolonged in patients with hepatic impairment; a lower or less frequent dose of fluoxetine should be used in these patients.
  • Cirrhosis patients: Administer a lower dose or less frequent dosing interval.
  • Compensated cirrhosis without ascites: Administer 50% of normal dose.

• Is It safe with alcohol?

  Consumption of alcohol must be avoided.

Below is the list of medicines, which have the same composition, strength and form as Flunil 20 MG Capsule , and hence can be used as its substitute.

• Fludac 20 MG Capsule

  Cadila Pharmaceuticals Ltd

• Noc 20 MG Capsule

  Orchid Chemicals & Pharmaceuticals Ltd

• Platin 20 MG Capsule

  Wockhardt Ltd

• Nuzac 20 MG Capsule

  Cipla Ltd

• Barozac 20 MG Capsule

  Baroda Pharma Pvt. Ltd

• Missed Dose instructions

  Take the missed dose as soon as you remember. If its almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

• Overdose instructions

  Seek emergency medical treatment or contact the doctor in case of an overdose.

This medication belongs to the class selective serotonin reuptake inhibitors. It works by inhibiting the reuptake of serotonin thus increasing its concentration in the brain and helps in reducing the symptoms.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

• Interaction with Alcohol

  Consumption of alcohol with this medicine is not recommended as it can result in dizziness and difficulty in concentration. Avoid activities that need mental alertness like driving or operating heavy machinery.

• Interaction with Lab Test

  Albumin level is increased while the patient is taking Fluoxetine. This inferred to a false positive result for the same.

• Interaction with Medicine

  • CYP2D6 enzyme substrate (minor), CYP3A3/4 enzyme substrate; CYP2C9 enzyme inducer; CYP1A2, 2C19, 2D6, and 3A3/4 enzyme inhibitor.
  • Flunil 20 MG Capsule inhibits the metabolism of tricyclic antidepressants (amitriptyline, desipramine, imipramine, nortriptyline) resulting is elevated serum levels; if combination is warranted, a low dose of TCA (10-25 mg/day) should be utilized.
  • Flunil 20 MG Capsule may cause hyponatremia; additive hyponatremic effects may be seen with combined use of a loop diuretic (bumetanide, furosemide, torsemide); monitor for hyponatremia.
  • Flunil 20 MG Capsule inhibits the reuptake of serotonin; combined use with a serotonin agonist (buspirone) may cause serotonin syndrome.
  • Flunil 20 MG Capsule may inhibit the metabolism of carbamazepine resulting in increased carbamazepine levels and toxicity; monitor for altered CBZ response.
  • Cyproheptadine, a serotonin antagonist may inhibit the effects of serotonin reuptake inhibitors (Flunil 20 MG Capsule); monitor for altered antidepressant response.
  • Flunil 20 MG Capsule inhibits the metabolism of dextromethorphan; visual hallucinations occurred in a patient receiving this combination; monitor for serotonin syndrome.
  • Flunil 20 MG Capsule may inhibit the metabolism of haloperidol and cause extrapyramidal symptoms (EPS); monitor patients for EPS if combination is utilized.
  • Flunil 20 MG Capsule should not be used with nonselective MAOIs (isocarboxazid, phenelzine). Fatal reactions have been reported. Wait 5 weeks after stopping Flunil 20 MG Capsule before starting an MAOI and 2 weeks after stopping an MAOI before starting Flunil 20 MG Capsule.
  • Patients receiving Flunil 20 MG Capsule and lithium have developed neurotoxicity. If combination is used, monitor for neurotoxicity.
  • Flunil 20 MG Capsule may inhibit the metabolism of metoprolol and propranolol resulting in cardiac toxicity; monitor for bradycardia, hypotension, and heart failure if combination is used.
  • Flunil 20 MG Capsule inhibits the reuptake of serotonin; combined use with other drugs which inhibit the reuptake (nefazodone, sibutramine) may cause serotonin syndrome. Monitor patient for altered response with nefazodone; avoid sibutramine combination.
  • Flunil 20 MG Capsule inhibits the metabolism of phenytoin and may result in phenytoin toxicity; monitor for phenytoin toxicity (ataxia, confusion, dizziness, nystagmus, involuntary muscle movement).
  • Flunil 20 MG Capsule has been reported to cause mania or hypertension when combined with selegiline; this combination is best avoided.
  • Flunil 20 MG Capsule may inhibit the metabolism of lovastatin and simvastatin resulting in myositis and rhabdomyolysis; these combinations are best avoided.
  • Flunil 20 MG Capsule combined with tramadol (serotonergic effects) may cause serotonin syndrome; monitor.
  • Flunil 20 MG Capsule may inhibit the metabolism of trazodone resulting in increased toxicity; monitor.
  • Flunil 20 MG Capsule inhibits the reuptake of serotonin; combination with tryptophan, a serotonin precursor, may cause agitation and restlessness; this combination is best avoided.
  • Flunil 20 MG Capsule may alter the hypoprothombinemic response to warfarin; monitor.

• Interaction with Disease

  Depression

  Use with caution the patients suffering from depression and other psychiatric disorders due to the increased risk of suicidal thoughts especially at the beginning of the treatment and at the time of dose change. Discontinue the medicine and inform the doctor if these symptoms appear.

  Glaucoma

  Use with caution in the patients with angle-closure glaucoma or history of glaucoma due to the risk of increasing the intraocular pressure.

• Interaction with Food

  Information not available.